Yearly Archives: 2021

“Our Modelling Failed to Anticipate”. Will Vulnerable Commercial Banks Sink the Economy by Acquiring BNPL Lenders?

In 2008, the global economy virtually collapsed due to the sub-prime mortgage crisis, brought on by loose credit policies and the propensity of the public to engage in the acquisition of homes well beyond their debt service capabilities. Sub-prime credit

Posted in Portfolio Model Subscription

Lack of Efficacy by Sinovac Covid-19 Vaccine Infers that Repression and Innovation ARE Mutually Exclusive.

Q. How Many Nobel Prizes have been awarded since the creation of the Nobel Prize in 1901? A. 919. Q. How many citizens of the Peoples Republic of China, the world’s second largest economy, a nation of 1.439 billion mainland

Posted in Portfolio Model Subscription

SwissMedic Approval of Lonza (LONN-SW, $587.40 CHF) Facilities Will Determine Moderna (MRNA-NYSE, $132.04) Vaccine Output for 2021.

https://finance.yahoo.com/news/lonza-awaits-licence-swiss-plant-104059985.html

Posted in Portfolio Model Subscription

Dreadful Efficacy Rates of Sinovac Covid Vaccine in Brazil Suggests Longer Revenue Streams and Higher Sustainable Pricing for mRNA Based Vaccines are Likely.

The announcement by Sinovac that their Covid vaccine has an official success rate of just 50.34%, which is suspect due to the requirement of a minimum 50% threshold by the WHO for approval for sale to countries lacking their own

Posted in Portfolio Model Subscription

Blurred Lines Separate the Investment Collector From the Investment Hoarder.

Successful collectors of investments earn above investment inflation returns, demonstrate discipline in their acquisition plan and do not accept external validation as a top-up payment in lieu of capital return. To my great chagrin, an impressive number of self-declared investment

Posted in Open Blog
Recent Comments
    Archives